1. Home
  2. RBBN vs GOSS Comparison

RBBN vs GOSS Comparison

Compare RBBN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$3.01

Market Cap

671.1M

Sector

Technology

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.50

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
GOSS
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.1M
726.8M
IPO Year
2000
2019

Fundamental Metrics

Financial Performance
Metric
RBBN
GOSS
Price
$3.01
$3.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
6
Target Price
$6.00
$8.60
AVG Volume (30 Days)
712.9K
2.9M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$868,592,000.00
$44,051,000.00
Revenue This Year
$5.02
N/A
Revenue Next Year
$5.74
$6.41
P/E Ratio
N/A
N/A
Revenue Growth
7.38
N/A
52 Week Low
$2.72
$0.71
52 Week High
$5.38
$3.60

Technical Indicators

Market Signals
Indicator
RBBN
GOSS
Relative Strength Index (RSI) 50.05 65.88
Support Level $2.73 $3.25
Resistance Level $2.95 $3.54
Average True Range (ATR) 0.10 0.19
MACD 0.05 0.02
Stochastic Oscillator 96.83 92.62

Price Performance

Historical Comparison
RBBN
GOSS

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: